The emergency use of the third vaccine was also recently approve in India. With the Coronavirus growing in number.
To people associated with it, the Russian-made Corona vaccine Sputnik V is likely to be import in India from next month.
As far as its construction in India is concerned, it may take until June or July at present.
Dimitri, CEO of the Russian Direct Investment Fund (RDIF), says that for manufacture in India could begin in late June or early July through various local tie-ups.
Dr. Reddy’s Labs, which has a license to distribute the vaccine. On Tuesday received India’s Drug Controller’s approval for the import of the vaccine under restricted use in an emergency.
In addition to a partnership with Dr. Reddy’s Labs, which is conducting Sputnik V clinical trials locally and which has distribution rights to Russian vaccines i.e. RDIF has spoken with five other local companies for production.
ompanies are: Stellis Biopharma, Gland Pharma, Hetero Biopharma, Panacea Biotech and Virchow Biotech.
India will produce at least five crore doses of Sputnik V in the next few months. Kirill Dimitri said, “We are seeing imports of five crore doses of Sputnik V in India this summer or by the end of the summer.
India has a significant production capacity. We have already started mass production of Sputnik V We have announced tie-ups with five local companies. We intend to do many more tie-ups which will be announced soon. ”
“Sputnik V testing in India has shown a high level of immune response.
Have got the same results not only in Russia, but also in Argentina, Mexico and other countries where the vaccine is used. Sputnik V provides a high degree of protection. Sputnik is more than 90 effective. “
Discussion about this post